Vistusertib,AZD4547,Capivasertib,Sapitinib,Selumetinib,Vandetanib,durvalumab,savolitinib,Olaparib
astrazeneca,sanofi,hutchmed,merck
['action i']
looking forward to present our study on #ctdna #tumorfraction in safir 02 immuno maintenance study! see you this afternoon at #asco23, session developmental therapeutics immunotherapy (e450)! 
M.d., medical oncologist 
Gustave Roussy
PhD at University of Bologna